glp-1 heart issues Can agonists treat cardiovascular diseases? Glucagon-Like Peptide-1 Agonist Use in

While much of the research remains in preclinical stages, early findings are promising

Conclusion The rise of GLP-1 microdosing may help patients achieve a more targeted approach to managing the unique metabolic shifts of perimenopause and menopause

Hair shedding, duller skin, weaker nails can occur when taking GLP-1 medications

Medicare does cover GLP-1s for FDA-approved uses other than weight loss, including type 2 diabetes, reducing cardiovascular risk and obstructive sleep apnea

Walliman T, Tokarska-Schlattner , Schlattner U

Allow Trulicity at least 30 minutes to warm up to room temperature first so that it is less likely to sting